Isomorphic Labs, a Google DeepMind spinoff, will soon start human trials of drugs designed using its Nobel Prize–winning AI protein-folding technology.

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers evaluate the growing flood of AI-generated potential drug molecules.

Isomorphic Labs, the DeepMind spin-off focused on AI-driven drug discovery, has revealed an exclusive new AI model that scientists say surpasses current benchmarks, offering a glimpse of what AlphaFold 4 may bring to pharmaceutical research and molecular biology.

Merck partners with Mayo Clinic to leverage AI, advanced analytics, and the Mayo Clinic Platform's genomic and clinical data for drug discovery and precision medicine. The collaboration initially targets inflammatory bowel disease, atopic dermatitis, and multiple sclerosis.

Demis Hassabis reveals 17 AI drug development projects at Davos, predicting robotics breakthrough and golden age of scientific discovery.

AI biotech startup Chai Discovery completes Series B funding and announces partnership with Eli Lilly to accelerate drug discovery using generative design models.